v3.26.1
Condensed Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Gain (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2024 $ 343,151 $ 5 $ 593,687 $ 770 $ (251,311)
Beginning balance (in shares) at Dec. 31, 2024   50,749,945      
Issuance of common stock pursuant to pre-funded warrant exercise, shares   2,000,069      
Issuance of common stock under benefit plans, Shares   335,626      
Issuance of common stock under benefit plans 2,187   2,187    
Vesting of shares of common stock subject to repurchase 3   3    
Vesting of shares of common stock subject to repurchase, Share   4,317      
Stock-based compensation 6,422   6,422    
Unrealized loss on marketable securities, net (82)     (82)  
Net Income (Loss) (28,147)       (28,147)
Ending balance at Mar. 31, 2025 323,534 $ 5 602,299 688 (279,458)
Ending balance (in shares) at Mar. 31, 2025   53,089,957      
Beginning balance at Dec. 31, 2024 343,151 $ 5 593,687 770 (251,311)
Beginning balance (in shares) at Dec. 31, 2024   50,749,945      
Net Income (Loss) (56,245)        
Ending balance at Jun. 30, 2025 302,147 $ 5 609,262 436 (307,556)
Ending balance (in shares) at Jun. 30, 2025   53,233,494      
Beginning balance at Mar. 31, 2025 323,534 $ 5 602,299 688 (279,458)
Beginning balance (in shares) at Mar. 31, 2025   53,089,957      
Issuance of common stock under benefit plans, Shares   143,537      
Issuance of common stock under benefit plans 583   583    
Stock-based compensation 6,380   6,380    
Unrealized loss on marketable securities, net (252)     (252)  
Net Income (Loss) (28,098)       (28,098)
Ending balance at Jun. 30, 2025 302,147 $ 5 609,262 436 (307,556)
Ending balance (in shares) at Jun. 30, 2025   53,233,494      
Beginning balance at Dec. 31, 2025 259,177 $ 5 630,037 393 (371,258)
Beginning balance (in shares) at Dec. 31, 2025   53,706,357      
Issuance of common stock under at-the-market offering program, net of $2.1 million of issuance costs   4,690,532      
Issuance of common stock under at-the-market offering program, net of $2.1 million of issuance costs, value 147,853 $ 1 147,852    
Issuance of common stock under benefit plans, Shares   1,072,798      
Issuance of common stock under benefit plans 12,289   12,289    
Stock-based compensation 7,847   7,847    
Unrealized loss on marketable securities, net (286)     (286)  
Net Income (Loss) (39,305)       (39,305)
Ending balance at Mar. 31, 2026 387,575 $ 6 798,025 107 (410,563)
Ending balance (in shares) at Mar. 31, 2026   59,469,687      
Beginning balance at Dec. 31, 2025 259,177 $ 5 630,037 393 (371,258)
Beginning balance (in shares) at Dec. 31, 2025   53,706,357      
Net Income (Loss) (84,863)        
Ending balance at Jun. 30, 2026 353,664 $ 6 810,359 (580) (456,121)
Ending balance (in shares) at Jun. 30, 2026   59,662,877      
Beginning balance at Mar. 31, 2026 387,575 $ 6 798,025 107 (410,563)
Beginning balance (in shares) at Mar. 31, 2026   59,469,687      
Issuance of common stock under benefit plans, Shares   193,190      
Issuance of common stock under benefit plans 2,102   2,102    
Stock-based compensation 10,232   10,232    
Unrealized loss on marketable securities, net (687)     (687)  
Net Income (Loss) (45,558)       (45,558)
Ending balance at Jun. 30, 2026 $ 353,664 $ 6 $ 810,359 $ (580) $ (456,121)
Ending balance (in shares) at Jun. 30, 2026   59,662,877